Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients

References

• Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999; 94: 909–913
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009; 113: 2386–2393
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106: 2244–2251
   PubMed Web of Science ®Google Scholar
• Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 2003; 349: 831–836
   PubMed Web of Science ®Google Scholar
• British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574–596.
   Google Scholar
• Rodeghiero F. First-line therapies for immune thrombocytopenic purpura: Re-evaluating the need to treat. Eur J Haematol 2008; 69: 19–26
   Google Scholar
• Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004; 104: 2623–2634
   PubMed Web of Science ®Google Scholar
• Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: A systematic review. Ann Intern Med 2004; 140: 112–120
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: Pathogenic and clinical diversity. Blood 2009; 113: 6511–6521
   PubMed Web of Science ®Google Scholar
• Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: Results of a prospective multicenter phase 2 study. Blood 2008; 112: 999–1004
   PubMed Web of Science ®Google Scholar
• Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, Kloczko J, Hassani H, Mayer B, Stone NL, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 357: 2237–2247
   PubMed Web of Science ®Google Scholar
• Zoghlami-Rintelen C, Weltermann A, Bittermann C, Kyrle PA, Pabinger I, Lechner K, Wenzl E. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia. Ann Hematol 2003; 82: 290–294
   PubMedGoogle Scholar
• Kumar S, Diehn FE, Gertz MA, Tefferi A. Splenectomy for immune thrombocytopenic purpura: Long-term results and treatment of postsplenectomy relapses. Ann Hematol 2002; 81: 312–319
   PubMed Web of Science ®Google Scholar
• Mazzucconi MG, Arista MC, Peraino M, Chistolini A, Felici C, Francavilla V, Macale E, Conti L, Gandolfo GM. Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy. Eur J Haematol 1999; 62: 219–222
   PubMed Web of Science ®Google Scholar
• Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M. on bealf of the Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto (GIMEMA). Efficacy and safety of splenectomy in immune thrombocytopenic purpura: Long-term results of 402 cases. Haematologica 2005; 90: 72–77
   PubMed Web of Science ®Google Scholar
• McMillan R, Durette C. Long term outcomes in adults with chronic ITP after splenectomy failure. Blood 2004; 104: 956–960
   PubMed Web of Science ®Google Scholar
• Fabris F, Tassan T, Ramon R, Carraro G, Randi ML, Luzzatto G, Moschino P, Girolami A. Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura. Br J Haematol 2001; 112: 637–640
   PubMed Web of Science ®Google Scholar
• Fenaux P, Caulier MT, Hirschauer MC, Beuscart R, Goudemand J, Bauters F. Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): A report on 181 cases. Eur J Haematol 1989; 42: 259–264
   PubMed Web of Science ®Google Scholar
• Duperier T, Brody F, Felsher J, Walsh RM, Rosen M, Ponsky J. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch Surg 2004; 139: 61–66
   PubMedGoogle Scholar
• Balagué C, Vela S, Targarona EM, Gich IJ, Muñiz E, D'Ambra A, Pey A, Monllau V, Ascaso E, Martinez C, et al. Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura: Study of clinical and laboratory data. Surg Endosc 2006; 20: 1208–1213
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Sabapathy K, Bharadwaj TP, Sethuraman S. Role of splenectomy in chronic idiopathic thrombocytopenic purpura. J Assoc Physicians India 2003; 51: 159–162
   PubMedGoogle Scholar
• Law C, Marcaccio M, Tam P, Heddle N, Kelton JG. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Eng J Med 1997; 336: 1494–1498
   PubMed Web of Science ®Google Scholar
• Ruivard M, Caulier MT, Vantelon JM, Tournilhac O, Schaeffer A, Godeau B, Bierling P. The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. Br J Haematol 1999; 105: 1130–1132
   PubMedGoogle Scholar
• Lozano-Salazar RR, Herrera MF, Vargas-Vorackova F, Lopez-Karpovitch X. Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Am J Surg 1998; 176: 366–369
   PubMed Web of Science ®Google Scholar
• Friedman RL, Hiatt JR, Korman JL, Facklis K, Cymerman J, Phillips EH. Laparoscopic or open splenectomy for hematologic disease: Which approach is superior?. J Am Coll Surg 1997; 185: 49–54
   PubMedGoogle Scholar
• Delaitre B, Blezel E, Samama G, Barrat C, Gossot D, Bresler L, Meyer C, Heyd B, Collet D, Champault G. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Surg Laparosc Endosc Percutan Tech 2002; 12: 412–419
   PubMedGoogle Scholar
• Cordera F, Long KH, Nagorney DM, McMurtry EK, Schleck C, Ilstrup D, Donohue JH. Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura: Clinical and economic analysis. Surgery 2003; 134: 45–52
   PubMed Web of Science ®Google Scholar
• Rodegheiro F, Frezzato M, Schiavotto C, Castaman G, Dini E. Fulminant sepsis in adults splenectomised for idiopathic thrombocytopenic purpura. Haematologica 1992; 77: 153–156
   Google Scholar
• Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001; 97: 2549–2554
   PubMed Web of Science ®Google Scholar
• Zaja F, Baccarani M, Mazza P, Bocchia M, Gugliotta L, Zaccaria A, Vianelli N, Defina M, Tieghi A, Amadori S, et al. Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood 2010; 115: 2755–2762
   PubMed Web of Science ®Google Scholar